Health groups want to widen scope of EU patient information proposal
This article was originally published in Scrip
EU efforts to improve the provision of medicines information to the public have had a rocky ride so far, with accusations that they could open the door to US-style direct-to-consumer advertising. And now patient advocacy groups are claiming that the new legislation will fail to achieve its aims unless health literacy standards are raised across the EU.
You may also be interested in...
A new licensing route is to be introduced by the UK MHRA next year for products that meet specific criteria, such as treating life threatening conditions or rare diseases and where there is a significant patient need. At a webinar this week, an MHRA medical assessor looked at the requirements that products will have to meet to enter the new pathway.
Russia seeks WHO endorsement of its Sputnik V vaccine, a UK BioIndustry Association taskforce identifies potential new antibody cocktails, and the European Centre for Disease Prevention and Control considers the best strategies for targeted vaccination programs.
New guidance from the UK covers the recognition of EU approvals, accelerated assessment, rolling reviews, and much else besides.